View on market: Volatility persists, eagerly searching for growth:
Global markets are showing a positive trend as softer US inflation data reduced concerns about immediate Federal Reserve rate hikes. Asian equities advanced, supported by gains in Japan and South Korea. US stocks moved closer to record highs, with technology and chip stocks leading the recovery. However, European futures remained slightly weak during Asian trading hours. Investors are also watching bond markets closely as higher inflation and rising government borrowing continue to keep long-term yields elevated. The upcoming US bond auction will be an important indicator of investor demand. In India, benchmark indices ended lower in the previous session as investors remained cautious. Market sentiment was affected by uncertainty surrounding US-Iran tensions and efforts to restore shipping activity through the Strait of Hormuz. Overall, global sentiment remains positive, but geopolitical risks and elevated bond yields continue to limit market confidence.
Key Quarterly Results:
ALICON, AMBER, APEX, ARROWGREEN, AVANTIFEED, AXISCADES, BAJAJHIND, BALAJITELE, BIRLACAP, CENTUM, CESC, DENTA, DIACABS, ELCIDIN, ENGINERSIN, EXCELINDUS, FINOPB, FIRSTCRY, GALAXYSURF, GENUSPOWER, GOCLCORP, GODREJIND, HIKLASS, HINDALUMI, INDIGOPNTS, IPCALAB, JINDALPHOT, JINDALPOLY, JSWCEMENT, JTEKTINDIA, JUBLFOOD, KERNEX, MAHASTEEL, MAXHEALTH, MFSL, MINDACORP, MODISONLTD, OLECTRA, PAGEIND, POLYCHEM, RELAXO, SAMMAANCAP, SEAMECLTD, SOLARINDS, SPECTRUM, SRM, TAPARIA, TMPV, ZODIAC
Economic Calendar:
- USD: PPI and Continuing & Initial Jobless Claim Data on 13th August 2026.
- IND: WPI and Passenger Vehicle Sales Data and Foreign Reserves Data and Bank Loan & Deposit Growth Rate on 14th August 2026.
- USD: Retail Sales Data on 14th August 2026.
- IND: Unemployment Rate and Export & Import Data on 17th August 2026.
BROKERAGE RADAR:
JEFFERIES ON GRASIM:
Target ₹3910 Earlier Target ₹3600 Recommendation Accumulate, Standalone Business Momentum Accelerates, Sharp Q1 beat, with all segments outperforming, VSF & Chemicals rebounded on pricing tailwinds, while new biz continue to scale, Paints guiding for 50% YoY growth in FY27 & FY28 targets intact, B2B e-commerce is set to turn profitable by FY27-end.
MACQUARIE ON GMR AIRPORTS:
Target ₹125 Recommendation Outperform, Temporary traffic headwinds, structural story intact, Continue to see value creation shifting beyond traffic growth, Toward higher aero yields, non-aero monetisation and airport adjacencies, Near term focus remains on Hyderabad traffic recovery, Bhogapuram ramp-up, Nagpur integration and progress on real estate monetization.
JEFFERIES ON LENSKART:
Target ₹680 Earlier Target ₹600 Recommendation Accumulate, Authenticity Matters More Than Legacy, Q1 continues to build the story, with strong growth & sharp margin expansion, Market creation remains a top priority, with supply, rather than demand, being a key constraint in India, Company now plays at the bottom end with a fully loaded Rs 500 product, while a clear premiumization trend is visible, Margin improvement in international should put a key investor concern to rest.
CITI ON APOLLO HOSPITAL:
Target ₹10770 Recommendation Accumulate, Q1: Strong Execution Across Businesses, Hospitals EBITDA up 25% like for like, Despite the expansions, ROCE continues to remain strong at 28.5%, Company announced four new hospitals and now targets >5,800 beds addition over the next five years, Provides strong visibility on medium-term earnings growth, Apollo remains top India hospitals pick.
International Markets:
U.S & Europe:
| Particulars | 12th Aug | Chg. | Chg.(%) |
| Nasdaq | 26,588.49 | 143.04 | 0.54 |
| Dow | 53,770.27 | -21.58 | -0.04 |
| FTSE | 10,833.15 | -11.04 | -0.10 |
| CAC | 8,674.94 | -40.00 | -0.46 |
| DAX | 26,331.07 | -60.35 | -0.23 |
| Dow Fut.* | 53,834.00 | -37.00 | -0.07 |
*As per 13th August.
Asian markets:
| Particulars | 13th Aug | Chg. | Chg.(%) |
| GIFT Nifty | 24,423.00 | -47.50 | -0.19 |
| Nikkei | 68,557.00 | 1,032.94 | 1.53 |
| Straits Times | 5,699.43 | -21.32 | -0.37 |
| Hang Seng | 25,400.00 | -40.17 | -0.16 |
| Taiwan Weighted | 46,116.33 | 598.26 | 1.30 |
| KOSPI | 6,814.83 | 235.79 | 3.58 |
| Shanghai | 3,958.67 | 11.99 | 0.30 |
Stocks strong on Chart:
| Index | F&O | Cash |
| BHARTI AIRTEL | BHEL | APAR IND |
| EICHER MOTOR | BOSCH | MAN IND |
| HINDALCO | HINDCOPPER | MARKSANS PHA |
| ICICI BANK | MCX | OMDC |
| SBI BANK | MOTILAL OSWAL | PRICOL |
| ULTRATECH | NATIONAL ALUM | TD POWER SYST |
Commodities & Currency:
| Particulars | Current Price | Chg. (%) |
| USD/INR | 95.33 | -0.13 |
| Brent | 87.832 | -1.30 |
| Gold | 154,878.00 | 0.00 |
| Silver | 237,800.00 | 0.91 |
FIIs & DIIs:
| Particulars | 12th Aug | 11th Aug |
| FIIs | -1,002.50 | 258.55 |
| DIIs | 5,841.66 | 24.77 |
Source: Moneycontrol, Bloomberg Quint, Investing
News Updates:
| Bajel Projects: | It secures an EPC order worth over ₹600 crore under the WR-ER Inter-Regional Network Expansion Scheme. |
| Dixon Techn: | It will incorporate subsidiary Adivistar Electronics India, with Dixon holding a 51% stake. |
| Bajaj Healthcare: | It receives DCGI approval to manufacture and market Cenobamate API and Cenobamate tablets. |
| UltraTech: | It will acquire a 26% stake in Solaris Horizon Energy for ₹27.8 crore. |
| Jio Financial Services: | It enters into a JV agreement with Bank of America, with BofA to acquire up to a 49.9% stake in arm Jio Credit for ₹18,268 crore. |
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
- InCred Markets Limited (“the Company”), Formerly known as Elite Wealth Limited (The company is Wholly Owned Subsidiary of InCred Capital Financial Services Limited) does/ does not do business with companies covered in its research reports. Investors should be aware that the Company may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by the Company are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)Disclosure AppendixAnalyst Certification (For Reports)Vindhyachal Prasad, InCred Markets Limited, vindhyachal@elitestock.comThe analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in the Company.As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
- All of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
- No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all InCred Markets Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. The Company may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
InCred Markets Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of the Company. Analyst as officer or director: The Company’s policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale. Legal
Entities Disclosures
InCred Markets Limited (Formerly known as Elite Wealth Limited) (IML henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
The Company discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- IML or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
- IML or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
- IML or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
- IML or its associates have not received any compensation from the subject company in the past twelve months;
- IML or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
- IML or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- IML or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
- IML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
- In respect of Public Appearances
- IML or its associates have not received any compensation from the subject company in the past twelve months;
- The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by IML



